Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tip60-HDAC8-SMURF2-mediated β-TrCP1 degradation is a key mechanism for hypoxia-induced cell death and tissue injury. | Cell Mol Life Sci | 2025 | 41454922 | PubTator, text mining | PubMed |
| Protofibril Binding Peptides Recognize and Inhibit Huntingtin Amyloid Formation in vitro and in vivo. | bioRxiv | 2025 | 41279516 | PubTator, text mining | PubMed |
| Clinical and Molecular Findings in 17 Patients with Cornelia de Lange Syndrome: Four Novel Variants and an ANKRD11 Gene Variant. | Mol Syndromol | 2025 | 41230206 | PubTator, text mining | PubMed |
| Study of the association between HDAC8, SIRT1, and P53 gene expression with drug resistance in chronic myeloid leukemia patients. | BMC Cancer | 2025 | 41162917 | PubTator, text mining | PubMed |
| PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies. | ChemMedChem | 2025 | 41160773 | PubTator, text mining | PubMed |
| Sex-specific associations of gene expression with Alzheimer's disease neuropathology and ante-mortem cognitive performance. | Nat Commun | 2025 | 41145521 | PubTator, text mining | PubMed |
| Editorial: Opportunities and challenges in drug repurposing. | Front Pharmacol | 2025 | 41132545 | PubTator, text mining | PubMed |
| Novel Azaborine-Based Inhibitors of Histone Deacetylases (HDACs). | Molecules | 2025 | 41097439 | PubTator, text mining | PubMed |
| Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy. | Viruses | 2025 | 41012682 | PubTator, text mining | PubMed |
| Novel selective indole based histone deacetylase 10 inhibitors as anticancer therapeutics. | Sci Rep | 2025 | 41006293 | PubTator, text mining | PubMed |
| Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis. | Med Chem | 2025 | 41001797 | PubTator, text mining | PubMed |
| Biocompatible Chemistry: A Plug-and-Play Toolbox for Chemical Biology Research. | Chembiochem | 2025 | 41001731 | PubTator, text mining | PubMed |
| Epigenetics in neonatal necrotizing enterocolitis: current understanding and the potential involvement of m6A modification. | Front Pediatr | 2025 | 40963968 | PubTator, text mining | PubMed |
| Expression and Clinical Significance of Class Ⅰ Histone Deacetylases in the Serum of Patients With Psoriatic Arthritis. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2025 | 40948260 | PubTator, text mining | PubMed |
| The Anti-Leukemic Potential of Curcumin in Chronic Myeloid Leukemia: A Systematic Review of In Vitro Studies. | Food Sci Nutr | 2025 | 40927046 | PubTator, text mining | PubMed |
| Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α. | Leukemia | 2025 | 40897850 | PubTator, text mining | PubMed |
| Synthesis, In Silico, and Biological Evaluation of Non-Hydroxamate Benzoic Acid-Based Derivatives as Potential Histone Deacetylase Inhibitors (HDACi). | Chem Biodivers | 2025 | 40893045 | PubTator, text mining | PubMed |
| Exploring the uncharted role of cell senescence in rare diseases. | Orphanet J Rare Dis | 2025 | 40890826 | PubTator, text mining | PubMed |
| Hypoxia-Induced PRMT1 Lactylation Drives Vimentin Arginine Asymmetric Dimethylation in Tumor Metastasis. | Adv Sci (Weinh) | 2025 | 40884268 | PubTator, text mining | PubMed |
| The deacetylases HDAC1/HDAC2 control JAK2V617F-STAT signaling through the ubiquitin ligase SIAH2. | Signal Transduct Target Ther | 2025 | 40877230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=5